Real-world effectiveness and safety of vedolizumab induction therapy for Crohn's disease in Poland - a prospective, observational POLONEZ II study considering patients reported outcomes.

被引：0
|
作者：
Liebert, A. [1 ]
Klopocka, M. [1 ]
Cichoz-Lach, H. [2 ]
Michalak, A. [2 ]
Talar-Wojnarowska, R. [3 ]
Domzal-Magrowska, D. [3 ]
Filipiuk, A. [4 ]
Krogulecki, M. [4 ]
Kopertowska-Majchrzak, M. [5 ]
Eder, P. [6 ]
Stawczyk-Eder, K. [6 ]
Waszak, K. [6 ]
Zagorowicz, E. [7 ,8 ]
Wojciechowski, K. [9 ,10 ]
Drygala, S. [9 ]
机构：
[1] Nicolaus Copernicus Univ, Coll Medicum Bydgoszcz, Dept Gastroenterol & Nutr Disorders, Bydgoszcz, Poland
[2] Med Univ Lublin, Dept Gastroenterol, Lublin, Poland
[3] Med Univ Lodz, Dept Digest Tract Dis, Lodz, Poland
[4] Mil Inst Med, Dept Gastroenterol, Warsaw, Poland
[5] Gen Hosp, Dept Internal Dis, Miedzychod, Poland
[6] Poznan Univ Med Sci, H Swiecicki Univ Hosp, Dept Gastroenterol Dietet & Internal Dis, Poznan, Poland
[7] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Gastroenterol, Warsaw, Poland
[8] Med Ctr Postgrad Educ, Dept Gastroenterol Hepatol & Clin Oncol, Warsaw, Poland
[9] Takeda Pharma Sp Zoo, Med Affairs, Warsaw, Poland
[10] Dept Internal Dis, Independent Publ Hlth Care Ctr, Tarczyn, Poland
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P421
引用
收藏
页码：550 / 551
页数：2
相关论文
共 50 条
  • [41] Corticosteroid Use in Patients with Crohn's Disease Initiating Vedolizumab in the Real-World Setting
    Sands, Bruce
    Khalid, Javaria
    Barocas, Morris
    Raluy-Callado, Mireia
    Merinopoulou, Evie
    INFLAMMATORY BOWEL DISEASES, 2017, 23 : S26 - S26
  • [42] The Real-Life Experience of Vedolizumab Efficacy and Safety in Crohn's Disease: A Prospective Observational Multicenter Cohort Study
    Amiot, Aurelien
    Grimaud, Jean-charles
    Treton, Xavier
    Filippi, Jerome
    Pariente, Benjamin
    Peyrin-Biroulet, Laurent
    Boureille, Arnaud
    Buisson, Anthony
    Carbonnel, Franck
    Bourrier, Anne
    Nancey, Stephane
    Roblin, Xavier
    Marteau, Philippe R.
    Altwegg, Romain
    Moreau, Jacques
    Aubourg, Alexandre
    Savoye, Guillaume
    Pelletier, Anne Laure
    Fumery, Mathurin
    Bonaz, Bruno L.
    Bouhnik, Yoram
    GASTROENTEROLOGY, 2016, 150 (04) : S810 - S810
  • [43] Effectiveness and Safety of Induction Therapy with Upadacitinib for the Treatment of Perianal Crohn's Disease : Real-World Data from a GETAID Multicentre Cohort Study
    Richard, N.
    Altwegg, R.
    Seksik, P.
    Nancey, S.
    Nachury, M.
    Laharie, D.
    Amiot, A.
    Vuitton, L.
    Peyrin-Biroulet, L.
    Allez, M.
    Rouillon, C.
    Coffin, B.
    Pelletier, A. L.
    Uzzan, M.
    Amil, M.
    Hupe, M.
    Fumery, M.
    Bozon, A.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : I1225 - I1227
  • [44] Real-world clinical effectiveness and safety of vedolizumab and ustekinumab in biologic-naive patients with Crohn's disease by disease location: Results from the EVOLVE Expansion study
    Scharl, M.
    Christensen, B.
    Bressler, B.
    Brett, N. R.
    Gianchetti, L.
    Kamble, P.
    Adsul, S.
    Farhat, Z.
    Ferrante, M.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1194 - I1195
  • [45] Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study
    Chaparro, Maria
    Baston-Rey, Iria
    Fernandez-Salgado, Estela
    Gonzalez Garcia, Javier
    Ramos, Laura
    Diz-Lois Palomares, Maria Teresa
    Arguelles-Arias, Federico
    Iglesias Flores, Eva
    Cabello, Mercedes
    Rubio Iturria, Saioa
    Nunez Ortiz, Andrea
    Charro, Mara
    Ginard, Daniel
    Duenas Sadornil, Carmen
    Merino Ochoa, Olga
    Busquets, David
    Iyo, Eduardo
    Gutierrez Casbas, Ana
    Ramirez de la Piscina, Patricia
    Maia Bosca-Watts, Marta
    Arroyo, Maite
    Jose Garcia, Maria
    Hinojosa, Esther
    Gordillo, Jordi
    Martinez Montiel, Pilar
    Velayos Jimenez, Benito
    Quilez Ivorra, Cristina
    Vazquez Moron, Juan Maria
    Maria Huguet, Jose
    Gonzalez-Lama, Yago
    Munagorri Santos, Ana Isabel
    Manuel Amo, Victor
    Dolores Martin-Arranz, Maria
    Bermejo, Fernando
    Martinez Cadilla, Jesus
    Rubin de Celix, Cristina
    Fradejas Salazar, Paola
    Lopez San Roman, Antonio
    Jimenez, Nuria
    Garcia Lopez, Santiago
    Figuerola, Anna
    Jimenez, Itxaso
    Martinez Cerezo, Francisco Jose
    Taxonera, Carlos
    Varela, Pilar
    de Francisco, Ruth
    Monfort, David
    Molina Arriero, Gema
    Hernandez Camba, Alejandro
    Javier Garcia-Alonso, Francisco
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (11) : 1725 - 1736
  • [46] Real-World Clinical Effectiveness and Safety of Vedolizumab and Ustekinumab in Bio-Naive Patients With Early Crohn's Disease: Results From the EVOLVE Expansion Study
    Christensen, Britt
    Scharl, Michael
    Bressler, Brian
    Khan, Zaeem
    Halchenko, Yuliya
    Kamble, Pravin
    Adsul, Shashi
    Farhat, Zeinab
    Ferrante, Marc
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S637 - S638
  • [47] REAL-WORLD EFFECTIVENESS AND SAFETY OF TOFACITINIB IN CROHN'S DISEASE: A MULTI-CENTER STUDY
    Fenster, Marc
    Khatiwada, Aava
    Wang, Wenfei
    Dimopoulos, Christina
    Hirten, Robert
    Gutierrez, Alexandra
    Colombel, Jean Frederic
    Cohen, Benjamin
    Ciorba, Matthew A.
    Rubin, David T.
    Ungaro, Ryan C.
    Pekow, Joel R.
    Deepak, Parakkal
    GASTROENTEROLOGY, 2020, 158 (06) : S1211 - S1211
  • [48] The Real-World Effectiveness and Safety of Vedolizumab for Moderate-Severe Crohn's Disease: Results From the US VICTORY Consortium
    Dulai, Parambir S.
    Singh, Siddharth
    Jiang, Xiaoqian
    Peerani, Farhad
    Narula, Neeraj
    Chaudrey, Khadija
    Whitehead, Diana
    Hudesman, David
    Lukin, Dana
    Swaminath, Arun
    Shmidt, Eugenia
    Wang, Shuang
    Boland, Brigid S.
    Chang, John T.
    Kane, Sunanda
    Siegel, Corey A.
    Loftus, Edward V.
    Sandborn, William J.
    Sands, Bruce E.
    Colombel, Jean-Frederic
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (08): : 1147 - 1155
  • [49] Real-World Evidence of Effectiveness and Safety of Vedolizumab for Inflammatory Bowel Disease in Taiwan: A Prospective Nationwide Registry (VIOLET) Study
    Lin, Wei-Chen
    Tai, Wei-Chen
    Chang, Chung-Hsin
    Tu, Chia-Hung
    Feng, I-Che
    Shieh, Ming-Jium
    Chung, Chen-Shuan
    Yen, Hsu-Heng
    Chou, Jen-Wei
    Wong, Jau-Min
    Liu, Yu-Hwa
    Huang, Tien-Yu
    Chuang, Chiao-Hsiung
    Tsai, Tzung-Jiun
    Chiang, Feng-Fan
    Lu, Chien-Yu
    Hsu, Wen-Hung
    Yu, Fang-Jung
    Chao, Te-Hsin
    Wu, Deng-Chyang
    Ho, Ai-Sheng
    Lin, Hung-Hsin
    Feng, Chun-Lung
    Wu, Keng-Liang
    Wong, Ming-Wun
    Tung, Chien-Chih
    Lin, Chun-Chi
    Chen, Chia-Chang
    Hu, Huang-Ming
    Lu, Lung-Sheng
    Wang, Huann-Sheng
    Wu, I-Chen
    Kuo, Hsin-Yu
    Wu, Jia-Feng
    Yao Shih, Hsiang
    Ni, Yen-Hsuan
    Tang, Shu-Lun
    Chen, Peng-Hsu
    Wei, Shu-Chen
    INFLAMMATORY BOWEL DISEASES, 2023, 29 (11) : 1730 - 1740
  • [50] Real-world safety and effectiveness of sucroferric oxyhydroxide for treatment of hyperphosphataemia in dialysis patients: a prospective observational study
    Vervloet, Marc G.
    Boletis, Ioannis N.
    de Francisco, Angel L. M.
    Kalra, Philip A.
    Ketteler, Markus
    Messa, Piergiorgio
    Stauss-Grabo, Manuela
    Derlet, Anja
    Walpen, Sebastian
    Perrin, Amandine
    Ficociello, Linda H.
    Rottembourg, Jacques
    Wanner, Christoph
    Cannata-Andia, Jorge B.
    Fouque, Denis
    CLINICAL KIDNEY JOURNAL, 2021, 14 (07) : 1770 - 1779
12345